August 22, 2019 07:54 AM EDTUpdated 10:44 AM

Sir Andrew Dillon, NICE's first — and only — chief executive to step down next year

Natalie Grover

Reporter

Using a laptop borrowed from his former employer, South London’s St George’s Hospital, Sir Andrew Dillon set about establishing NICE — launched by the then health …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sir Andrew Dillon, NICE's first — and only — chief executive to step down next year

Natalie Grover

Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Sir An­drew Dil­lon, NICE's first — and on­ly — chief ex­ec­u­tive to step down next year

Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Sir Andrew Dillon, NICE's first — and only — chief executive to step down next year